Skip to content

A COMPARATIVE STUDY OF PREOPERATIVE VERSUS POSTOPERATIVE ADMINISTRATION OF 120 mg ETORICOXIBS IN MANDIBULAR THIRD MOLAR SURGERY: A RANDOMIZED SPLIT-MOUTH DOUBLE-BLINDED CLINICAL TRIAL

A COMPARATIVE STUDY OF PREOPERATIVE VERSUS POSTOPERATIVE ADMINISTRATION OF 120 mg ETORICOXIBS IN MANDIBULAR THIRD MOLAR SURGERY: A RANDOMIZED SPLIT-MOUTH DOUBLE-BLINDED CLINICAL TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20210726002
Enrollment
31
Registered
2021-07-26
Start date
2020-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Does preoperative administration of Etoricoxib 120 mg have the higher efficacy in reduction of postoperative pain in mandibular third molar surgery compared to postoperative administration of the same drug? Analgesia

Interventions

In the experimental group (A), a capsule of etoricoxib 120 mg was administered orally 30 minutes before the operation and the same identical capsule containing vitamin was given to ingest 4 hours afte
Treatment,Treatment
Group A: Etoricoxibs - Placebo,Group B: Placebo - Etoricoxibs

Sponsors

Department of Oral and Maxillofacial Surgery, Floor 13, faculty of Dentistry, Mahidol university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiologists ASA : class I or II 2. Patients with presence of asymptomatic, bilaterally similar partially or totally impacted lower third molars as classified by the inclination according to the Winter classification, class and position according to the Pell and Gregory classification that requires flap opening, bone removal, and tooth separation during the operation 3. Age 18 to 30 years

Exclusion criteria

Exclusion criteria: 1. Patients with any history of allergy to non-steroidal anti-inflammatory drugs 2. Presence of systemic disease that contraindicates the surgical procedure such as uncontrolled hypertension, uncontrolled diabetes, asthma, and any pathological disease 3. Pre-existing acute infection and inflammation 4. Patients with a history of narcotic or alcohol abuse 5. Chronic opioid analgesic use 6. Pregnancy and lactating mother 7. The surgical time exceeding 120 minutes or any surgical complications occurred that would render the procedures non-comparable 8. Unable to follow the instructions or refusal to the follow-up appointments

Design outcomes

Primary

MeasureTime frame
Comparison of postoperative pain 6 months Numerical rating scale (NRS)

Secondary

MeasureTime frame
Comparison of total rescue analgesic requirement 6 months Total rescue analgesic requirement

Countries

Thailand

Contacts

Public ContactSirichai Kiattavorncharoen

Faculty of dentistry, Mahidol university

sirichai.kia@mahidol.ac.th0817316491

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026